MECHANISM CATEGORIES SAFETY Side effects Generally well-tolerated in trials at the doses tested Injection-site reactions Known interactions Not characterized in Phase 3 Contraindications Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Not FDA-approved as a drug
[PubMed] [Google Scholar] 94.Djakovic Z., Djakovic I., Cesarec V., Madzarac G., Becejac T., Zukanovic G., Drmic D., Batelja L., Zenko Sever A., Kolenc D., et al
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation
Stronger appetite suppression Some people do not respond to Ozempic alone
For those with normal absorption and adequate B12 stores, injections provide no unique metabolic advantage
You have simply created a lower concentration than intended, which means you will draw a larger volume per dose